Headaches are a recognized side effect of semaglutide (Ozempic, Wegovy), reported by roughly 6–9% of participants in clinical trials. They are most common during the first few weeks of treatment or after a dose increase, and they typically ease on their own as your body adjusts. For most people, headaches are temporary and manageable — not a reason to stop medication.
Why Does Semaglutide Cause Headaches?
No single mechanism fully explains semaglutide-related headaches, but researchers and clinicians point to several overlapping factors:
- Reduced calorie and fluid intake. Semaglutide suppresses appetite significantly. Many people unintentionally eat and drink less, leading to mild dehydration and lower blood sugar — both classic headache triggers.
- GLP-1 receptor activity in the brain. GLP-1 receptors exist throughout the central nervous system. According to Drucker DJ (Cell Metabolism, 2006), GLP-1 signaling affects areas involved in appetite, nausea, and autonomic regulation. Stimulating these pathways during early treatment may contribute to head pain in some people.
- Blood pressure shifts. Semaglutide modestly lowers blood pressure in many users. A sudden drop, especially when standing up, can trigger a short-lived headache.
- Nausea-related tension. Nausea — one of the most common semaglutide side effects per FDA labeling — often causes people to tense their neck and shoulder muscles, which can radiate into a tension-type headache.
- Dose escalation. Each time the dose steps up, the body experiences a fresh wave of GLP-1 stimulation, which can briefly restart mild side effects including headache.
The most common and fixable cause of semaglutide headaches is dehydration. Because the medication blunts hunger and thirst cues, many people simply forget to drink enough water. Aiming for at least 8 cups (64 oz) of fluid daily can reduce headache frequency significantly — and is the first thing to try before assuming a more complex cause.
When Do Headaches Typically Start and Stop?
Headaches tend to follow the same general timeline as other GLP-1 side effects: they peak early and fade as the body adapts. The table below reflects patterns reported in the STEP 1 trial (Wilding et al., NEJM, 2021) and the Wegovy prescribing information, combined with the standard dose-escalation schedule.
| Week | Dose (Wegovy) | Headache Pattern |
|---|---|---|
| 1–4 | 0.25 mg weekly | Mild headaches possible as body adjusts to GLP-1 activity; dehydration risk rises as appetite drops |
| 5–8 | 0.5 mg weekly | Headaches may briefly increase after dose step-up, then settle within 1–2 weeks |
| 9–12 | 1 mg weekly | Another potential uptick at dose increase; most people report improvement by end of this phase |
| 13–16 | 1.7 mg weekly | Headaches uncommon at this stage for most users; individual variation exists |
| 17+ | 2.4 mg weekly (maintenance) | Headaches largely resolved for the majority; persistent headache warrants prescriber discussion |
What Can You Do to Reduce Headaches?
Several straightforward strategies can lessen the frequency and severity of semaglutide-related headaches:
- Drink water consistently throughout the day — not just when you feel thirsty, since thirst cues are blunted on this medication.
- Keep up with electrolytes. If you are eating much less, sodium, potassium, and magnesium intake may drop. Broth, diluted sports drinks, or electrolyte tablets can help.
- Eat on a schedule. Even small, regular meals help prevent blood sugar dips that trigger headaches. Skipping meals entirely is a common mistake on GLP-1 medications.
- Move slowly when standing up. This reduces the chance of a blood pressure dip causing a brief head rush or headache.
- Use OTC pain relief if needed. Acetaminophen (Tylenol) or ibuprofen (Advil) are generally appropriate for occasional headaches. Always check with your pharmacist or prescriber if you have kidney concerns or other conditions that limit NSAID use.
- Track injection timing. Some people notice headaches in the 24–48 hours after injection. Noting the pattern helps you plan around it.
When Should You Talk to Your Doctor?
Most semaglutide headaches are mild and self-limiting. However, certain warning signs mean you should contact your prescriber promptly:
- Headaches that are severe, sudden, or described as "the worst of your life"
- Headaches accompanied by vision changes, confusion, or weakness
- Headaches that persist beyond 4–6 weeks without improvement
- Frequent headaches that interfere with daily activities or sleep
- Headaches combined with signs of low blood sugar (shakiness, sweating, rapid heartbeat), particularly if you also take insulin or a sulfonylurea
Persistent or worsening headaches can also be a signal that the dose escalation schedule needs to be slowed. The FDA-approved titration schedule is a minimum — your prescriber can always extend time at a lower dose if side effects are burdensome.
Frequently Asked Questions
Headaches on semaglutide are common, usually short-lived, and often tied to manageable factors like dehydration or reduced food intake. Still, your prescriber is your best resource for deciding whether a headache pattern is typical adjustment or something worth investigating further. Before changing your dose or adding any medication — even over-the-counter options — have that conversation with your care team so your treatment plan stays on track.
- Wilding JPH et al., STEP 1 trial, New England Journal of Medicine, 2021
- Marso SP et al., SUSTAIN-6 trial, New England Journal of Medicine, 2016
- FDA, Wegovy (semaglutide) Prescribing Information, 2021
- FDA, Ozempic (semaglutide) Prescribing Information, 2017
- Drucker DJ, "The biology of incretin hormones", Cell Metabolism, 2006